Special Issue “Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations 2022”-Reference-Cited by-同舟云学术

Special Issue “Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations 2022”

Published:2023-04-27 Issue:5 Volume:16 Page:652
ISSN:1424-8247
Container-title:Pharmaceuticals
language:en
Short-container-title:Pharmaceuticals

Author:

Ruaro Barbara¹^ORCID,Baron Murray²,Rosato Edoardo³^ORCID,Martini Romeo⁴,Confalonieri Marco¹^ORCID

Affiliation:

1. Pulmonology Unit, Department of Medical Surgical and Health Sciences, University Hospital of Cattinara, University of Trieste, 34149 Trieste, Italy

2. Division of Rheumatology, Jewish General Hospital, McGill University, Montreal, QC 3755, Canada

3. Department of Translational and Precision Medicine, Sapienza University of Rome, 00185 Rome, Italy

4. Unit of Angiology, AULSS 1 Dolomiti, Ospedale San Martino, 32100 Belluno, Italy

Abstract

This Special Issue, titled “Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations”, aims to demonstrate recent and new advances and future trends in the field of rheumatic diseases [...]

Publisher

MDPI AG

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://www.mdpi.com/1424-8247/16/5/652/pdf

Reference11 articles.

1. Ruaro, B., Confalonieri, M., Matucci-Cerinic, M., Salton, F., Confalonieri, P., Santagiuliana, M., Citton, G.M., Baratella, E., and Bruni, C. (2021). The Treatment of Lung Involvement in Systemic Sclerosis. Pharmaceuticals, 14.

2. Prospective capillaroscopy-based study on transition from primary to secondary Raynaud’s phenomenon: Preliminary results;Bernero;Reumatismo,2013

3. Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: A pilot study;Ruaro;Rheumatol. Int.,2019

4. Ruaro, B., Gandin, I., Pozzan, R., Tavano, S., Bozzi, C., Hughes, M., Kodric, M., Cifaldi, R., Lerda, S., and Confalonieri, M. (2023). Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy. Pharmaceuticals, 16.

5. Salem, H.F., Abd El-Maboud, M.M., Said, A.S.A., Salem, M.N., Sabry, D., Hussain, N., El-Ghafar, O.A.M.A., and Hussein, R.R.S. (2023). Nano Methotrexate versus Methotrexate in Targeting Rheumatoid Arthritis. Pharmaceuticals, 16.